Cargando…

Better Survival in Morbidly Obese Patients with Atrial Fibrillation Treated with Non-vitamin K-dependent Oral Anticoagulants

BACKGROUND: The efficacy and safety of non-vitamin K-dependent anticoagulants (NOAC) are not well investigated in the obese population, and fixed dosing could lead to under-anticoagulation. Our objective was to evaluate the effect of obesity on anticoagulation outcomes and survival in non-valvular a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albabtain, Monirah A., Alanazi, Zaid, Al Mutairi, Nawaf, Al Hebaishi, Yahya, Alyafi, Ola, Alghasoon, Haneen, Arafat, Amr A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Saudi Heart Association 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069674/ https://www.ncbi.nlm.nih.gov/pubmed/37020973 http://dx.doi.org/10.37616/2212-5043.1327

Ejemplares similares

Real-world Experience in Managing Atrial Fibrillation in Patients with Renal Impairment; Rivaroxaban versus Warfarin
por: Albabtain, Monirah Abdulrahman, et al.
Publicado: (2023)

Time in therapeutic range for virtual anticoagulation clinic versus in-person clinic during the COVID-19 pandemic: a crossover study
por: Alanazi, Zaid, et al.
Publicado: (2022)

HAS-BLED Score for Prediction of Bleeding and Mortality After Transcatheter Aortic Valve Replacement
por: Albabtain, Monirah A., et al.
Publicado: (2023)

Long-Term Effects of Postoperative Atrial Fibrillation following Mitral Valve Surgery
por: Alghosoon, Haneen, et al.
Publicado: (2023)

Assessment of the quality of anticoagulation management with warfarin in a tertiary care center
por: Albabtain, Monirah A., et al.
Publicado: (2020)

Rivaroxaban versus warfarin for the management of left ventricle thrombus
por: Albabtain, Monirah A., et al.
Publicado: (2021)

The development and validation of a multivariable model to predict the bleeding risk score for patients with non-valvular atrial fibrillation using direct oral anticoagulants in the Arab population
por: AlAmmari, Maha, et al.
Publicado: (2021)

Risk of Bleeding after Transcatheter Aortic Valve Replacement: impact of Preoperative Antithrombotic Regimens
por: Albabtain, Monirah A, et al.
Publicado: (2022)

Comparison of Outcomes After Transcatheter Versus Surgical Repeat Mitral Valve Replacement
por: Arafat, Amr A., et al.
Publicado: (2023)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Relation of the ‘Atrial Fibrillation Better Care (ABC) Pathway’ to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists
por: Roldán, Vanessa, et al.
Publicado: (2022)

Real life behaviour of direct oral anticoagulants in patients with nonvalvular atrial fibrillation and morbid obesity
por: Navarro-Almenzar, Begoña, et al.
Publicado: (2021)

The trans-septal approach in transcatheter mitral valve-in-valve implantation for degenerative bioprosthesis
por: Otaiby, Mohammed Al, et al.
Publicado: (2020)

Better clinical outcome with direct oral anticoagulants in hospitalized heart failure patients with atrial fibrillation
por: Yoshihisa, Akiomi, et al.
Publicado: (2018)

One-Year Clinical Outcome in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study
por: Hammoudeh, Ayman, et al.
Publicado: (2022)

Pain perception assessment using the short-form McGill pain questionnaire after cardiac surgery
por: Alharbi, Hussam A., et al.
Publicado: (2020)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Anticoagulation in atrial fibrillation: the present and the future
por: Dweck, Marc R, et al.
Publicado: (2012)

Anticoagulation for atrial fibrillation in active cancer
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

Management of Tricuspid Valve Regurgitation During Surgical Ventricular Restoration for Ischemic Cardiomyopathy
por: Arafat, Amr A., et al.
Publicado: (2023)

Warfarin anticoagulation in hemodialysis patients with atrial fibrillation: comparison of nephrologist-led and anticoagulation clinic-led management
por: Bahbahani, Hamad, et al.
Publicado: (2018)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
por: Santangeli, Pasquale, et al.
Publicado: (2011)

The new oral anticoagulants in atrial fibrillation: an update
por: Verheugt, F. W. A.
Publicado: (2013)

Newer Anticoagulants for Non-Valvular Atrial Fibrillation
por: Harburger, Joseph M., et al.
Publicado: (2012)

MRI Screening for Chronic Anticoagulation in Atrial Fibrillation
por: Fisher, Mark
Publicado: (2013)

Satisfaction with oral anticoagulants in patients with atrial fibrillation
por: Suárez Fernández, Carmen, et al.
Publicado: (2018)

Anticoagulant Therapy for Frail Patients with Atrial Fibrillation
por: Hori, Hiroshi, et al.
Publicado: (2021)

Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy
por: Ko, Darae, et al.
Publicado: (2021)

Anticoagulation in patients with atrial fibrillation and liver cirrhosis
por: Karapedi, Eleni, et al.
Publicado: (2022)

Management of Atrial Fibrillation in Older Patients by Morbidity Burden: Insights From Get With The Guidelines‐Atrial Fibrillation
por: Dalgaard, Frederik, et al.
Publicado: (2020)

Use and Outcomes Associated With Bridging During Anticoagulation Interruptions in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
por: Steinberg, Benjamin A., et al.
Publicado: (2015)

The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review
por: Stevens, David, et al.
Publicado: (2021)

Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Moderate to Severe Mitral Stenosis: A Systematic Review
por: Al Rawahi, Mohamed N, et al.
Publicado: (2023)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Patterns of Anticoagulation Use in Patients With Cancer With Atrial Fibrillation and/or Atrial Flutter
por: Fradley, Michael G., et al.
Publicado: (2020)

Anticoagulation in Cancer Patients With Atrial Fibrillation or Atrial Flutter: Are There Gaps in Care?
por: Russo, Andrea M.
Publicado: (2020)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)

The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation
por: Antonucci, Emilia, et al.
Publicado: (2015)

Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation
por: da Silva, Rose M.F.L.
Publicado: (2014)

The Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial Fibrillation
por: Sholzberg, Michelle, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nl5ir4sb3sfjrjk3gjefmeq8j7